These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16805172)

  • 41. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma histamine elevation in a large cohort of sickle cell disease patients.
    Allali S; Lionnet F; Mattioni S; Callebert J; Stankovic Stojanovic K; Bachmeyer C; Arlet JB; Brousse V; de Montalembert M; Chalumeau M; Grateau G; Maciel TT; Launay JM; Hermine O; Georgin-Lavialle S
    Br J Haematol; 2019 Jul; 186(1):125-129. PubMed ID: 30924132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormalities of platelet aggregation in sickle cell disease.
    Mehta P; Mehta J
    J Pediatr; 1980 Feb; 96(2):209-13. PubMed ID: 7351581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The value of foetal haemoglobin level in the management of nigerian sickle cell anaemia patients.
    Omoti CE
    Niger Postgrad Med J; 2005 Sep; 12(3):149-54. PubMed ID: 16160713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.
    Amin MA; Amin AP; Kulkarni HR
    Ann Hematol; 2004 Jun; 83(6):331-5. PubMed ID: 15052371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet P-selectin expression in patients with sickle cell disease who undergo apheresis.
    Boga C; Ozdogu H; Kozanoglu I; Sozer O; Sezgin N; Kizilkilic E; Bakar C
    Ther Apher Dial; 2007 Aug; 11(4):255-61. PubMed ID: 17661830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma levels of platelet and vascular prostaglandin derivatives in children with sickle cell anaemia.
    Buchanan GR; Holtkamp CA
    Thromb Haemost; 1985 Aug; 54(2):394-6. PubMed ID: 4082079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion.
    Setty BN; Chen D; O'Neal P; Littrell JB; Grossman MH; Stuart MJ
    J Lab Clin Med; 1998 Apr; 131(4):344-53. PubMed ID: 9579388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of poloxamer 188 treatment on sickle cell vaso-occlusive crisis: computer-assisted intravital microscopy study.
    Cheung AT; Chan MS; Ramanujam S; Rangaswami A; Curl K; Franklin P; Wun T
    J Investig Med; 2004 Sep; 52(6):402-6. PubMed ID: 15612454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
    Setty BN; Chen D; Stuart MJ
    Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in platelet count as a predictive tool in sickle cell acute vaso-occlusive crises: a pediatric study.
    Shanley LA; Ebeling M; Titus MO
    Clin Pediatr (Phila); 2011 Jul; 50(7):657-61. PubMed ID: 21382920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of copper, zinc and disease severity scores in sickle cell disease patients in Benin City, Nigeria.
    Emokpae MA; Fatimehin EB; Obazelu PA
    Afr Health Sci; 2019 Sep; 19(3):2798-2805. PubMed ID: 32127853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel.
    Ohno K; Tanaka H; Samata N; Jakubowski JA; Tomizawa A; Mizuno M; Sugidachi A
    Thromb Res; 2014 Oct; 134(4):889-94. PubMed ID: 25130912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and Laboratory Predictors of Painful Vaso-Occlusive Crisis Among Sickle Cell Disease Patients: A Single-Center Study in Saudi Arabia.
    Zakaria O; Buhalim RA; Almulhim F; Al Jabr FA; Alrashid A; Almutairi M
    Cureus; 2021 May; 13(5):e14980. PubMed ID: 34123674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia.
    Piccin A; Murphy C; Eakins E; Kunde J; Corvetta D; Di Pierro A; Negri G; Guido M; Sainati L; Mc Mahon C; Smith OP; Murphy W
    J Extracell Vesicles; 2015; 4():28414. PubMed ID: 26609806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
    Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
    Hijazi Z; Onadeko BO; Khadadah M; Haider MZ; Adekile AD; Al-Habashi H
    Int J Clin Pract; 2005 Feb; 59(2):163-7. PubMed ID: 15854191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma concentration of fucosyltransferase 7 is not associated with the number of clinically overt vaso-occlusive events in sickle cell disease.
    Okpala IE; Eze OE; Ezekekwu CA; Nnakenyi ID; Ilechukwu GU; Akpa CO; Nwani EI; Maduka CJ; Anigbogu IO; Muoghalu ED; Ugwu NI; Ajuba IC; Aneke JC; Okoye HC; Nonyelu CC; Duru AN
    Ghana Med J; 2023 Sep; 57(3):198-203. PubMed ID: 38957672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.
    Bennewitz MF; Jimenez MA; Vats R; Tutuncuoglu E; Jonassaint J; Kato GJ; Gladwin MT; Sundd P
    JCI Insight; 2017 Jan; 2(1):e89761. PubMed ID: 28097236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha-thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changes.
    Renoux C; Connes P; Nader E; Skinner S; Faes C; Petras M; Bertrand Y; Garnier N; Cuzzubbo D; Divialle-Doumdo L; Kebaïli K; Renard C; Gauthier A; Etienne-Julan M; Cannas G; Martin C; Hardy-Dessources MD; Pialoux V; Romana M; Joly P
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.